Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Krishnan

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Vaccine|November 2, 2017
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomesA Landi, J Law, D Hockman, et al.
Child Psychiatry and Human Development|September 4, 2020
Measuring What Matters to Individuals with Angelman Syndrome and Their Families: Development of a Patient-Centered Disease Concept ModelTom Willgoss, Daiana Cassater, Siobhan Connor, et al.
Indian Journal of Pediatrics|November 1, 1996
Influence of parental literacy and socio-economic status on infant mortalityR S Rao, B K Chakladar, N S Nair, et al.
Dementia and Geriatric Cognitive Disorders|August 10, 2005
Prevalence of dementia among Veterans Affairs medical care system usersLaura L Krishnan, Nancy J Petersen, A Lynn Snow, et al.
Pediatrics|May 14, 2014
Common genetic variants and risk of brain injury after preterm birthJames P Boardman, Andrew Walley, Gareth Ball, et al.
Nature Reviews. Drug Discovery|May 18, 2021
Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunitiesMichelle L Krishnan, Elizabeth Berry-Kravis, Jamie K Capal, et al.
Nature Communications|September 7, 2017
Integrative genomics of microglia implicates DLG4 (PSD95) in the white matter development of preterm infantsMichelle L Krishnan, Juliette Van Steenwinckel, Anne-Laure Schang, et al.
Nature Medicine|July 11, 2025
The UBE3A-ATS antisense oligonucleotide rugonersen in children with Angelman syndrome: a phase 1 trialJörg F Hipp, Carlos A Bacino, Lynne M Bird, et al.
Journal of Neurodevelopmental Disorders|July 26, 2023
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)Jorrit Tjeertes, Carlos A Bacino, Terry Jo Bichell, et al.
Brain : a Journal of Neurology|October 31, 2019
Decreased microglial Wnt/β-catenin signalling drives microglial pro-inflammatory activation in the developing brainJuliette Van Steenwinckel, Anne-Laure Schang, Michelle L Krishnan, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Vaccine|November 2, 2017
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomesA Landi, J Law, D Hockman, et al.
Child Psychiatry and Human Development|September 4, 2020
Measuring What Matters to Individuals with Angelman Syndrome and Their Families: Development of a Patient-Centered Disease Concept ModelTom Willgoss, Daiana Cassater, Siobhan Connor, et al.
Indian Journal of Pediatrics|November 1, 1996
Influence of parental literacy and socio-economic status on infant mortalityR S Rao, B K Chakladar, N S Nair, et al.
Dementia and Geriatric Cognitive Disorders|August 10, 2005
Prevalence of dementia among Veterans Affairs medical care system usersLaura L Krishnan, Nancy J Petersen, A Lynn Snow, et al.
Pediatrics|May 14, 2014
Common genetic variants and risk of brain injury after preterm birthJames P Boardman, Andrew Walley, Gareth Ball, et al.
Nature Reviews. Drug Discovery|May 18, 2021
Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunitiesMichelle L Krishnan, Elizabeth Berry-Kravis, Jamie K Capal, et al.
Nature Communications|September 7, 2017
Integrative genomics of microglia implicates DLG4 (PSD95) in the white matter development of preterm infantsMichelle L Krishnan, Juliette Van Steenwinckel, Anne-Laure Schang, et al.
Nature Medicine|July 11, 2025
The UBE3A-ATS antisense oligonucleotide rugonersen in children with Angelman syndrome: a phase 1 trialJörg F Hipp, Carlos A Bacino, Lynne M Bird, et al.
Journal of Neurodevelopmental Disorders|July 26, 2023
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)Jorrit Tjeertes, Carlos A Bacino, Terry Jo Bichell, et al.
Brain : a Journal of Neurology|October 31, 2019
Decreased microglial Wnt/β-catenin signalling drives microglial pro-inflammatory activation in the developing brainJuliette Van Steenwinckel, Anne-Laure Schang, Michelle L Krishnan, et al.
Pageof 13